Recurrent or Refractory ANCA Associated Vasculitis
1 clinical trials · Condition
◉ Watch Recurrent or Refractory ANCA Associated Vasculitis
| Record | Firm | Date |
|---|---|---|
| the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases (NCT07339540) | Tongji Hospital | 2025-11-04 |
Track Recurrent or Refractory ANCA Associated Vasculitis automatically
Every clearance here is in the API, with alerts when new ones post.